DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mytelase (Ambenonium Chloride) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

Adverse effects of anticholinesterase agents such as MYTELASE usually result from overdosage and include muscarinic effects such as excessive salivation, abdominal cramps, diarrhea, miosis, urinary urgency, sweating, nausea, increase in bronchial and lacrymal secretions, and vomiting, and nicotinic effects such as muscle cramps, fasciculation of voluntary muscles, and rarely generalized malaise with anxiety and vertigo. (See OVERDOSAGE.)



REPORTS OF SUSPECTED MYTELASE SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Mytelase. The information is not vetted and should not be considered as verified clinical evidence.

Possible Mytelase side effects / adverse reactions in 63 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09

Patient: 63 year old male

Reactions: Dyspnoea, Functional Gastrointestinal Disorder, Hyperhidrosis, Myalgia, Malaise, Miosis, Salivary Hypersecretion, Cholinergic Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Mytelase
    Administration route: Oral
    Indication: Ocular Myasthenia
    Start date: 2010-09-01

Mytelase
    Administration route: Oral
    Start date: 2012-01-03
    End date: 2012-01-10



Possible Mytelase side effects / adverse reactions in 20 year old female

Reported by a consumer/non-health professional from Japan on 2012-05-07

Patient: 20 year old female

Reactions: Dyspnoea

Suspect drug(s):
Mytelase

Other drugs received by patient: Mestinon



Possible Mytelase side effects / adverse reactions in 88 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-05

Patient: 88 year old male

Reactions: OFF Label USE, Dermatitis Bullous, Fixed Eruption, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Suspect drug(s):
Mytelase
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-12

Mytelase
    Administration route: Oral
    Indication: Urinary Tract Disorder
    Start date: 2012-03-27
    End date: 2012-04-03

Other drugs received by patient: Atorvastatin; Aliskiren; Levothyroxine Sodium; Alfuzosin HCL; Bisoprolol Fumarate; Pentoxifylline



See index of all Mytelase side effect reports >>

Drug label data at the top of this Page last updated: 2008-09-04

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014